PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | |portal hypertension |
| Sentences | 75 |
| PubMedID- 20698946 | Introduction: varices of the colon are a rare cause of lower gastrointestinal bleeding, usually associated with portal hypertension due to liver cirrhosis or other causes of portal venous obstruction. |
| PubMedID- 24960036 | Objective: to investigate the effects and technical points of laparoscopic splenectomy and esophagogastric devascularization (ls+ed) for portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 22009385 | Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc). |
| PubMedID- 22114590 | Thus, despite its invasiveness, eus is a method that provides a reliable and unique assessment of the features of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25812120 | In some patients liver fibrosis leads to liver cirrhosis with portal hypertension, hepatocellular dysfunction and increased risk of hepatocellular carcinoma [2,3]. |
| PubMedID- 23248978 | Aim: to investigate the feasibility, effectiveness, and safety of a combination therapy of laparoscopic splenectomy (ls) with pericardial devascularization (pd) (laparoscopic hassab's procedure) with or without limited portacaval shunt (lps) for patients with portal hypertension due to liver cirrhosis. |
| PubMedID- 25701619 | Objective: we have compared the influences of three surgical strategies on the occurrence and development of portal vein thrombosis (pvt) in patients with liver cirrhosis complicated by portal hypertension (pht) in this study. |
| PubMedID- 25120838 | One of the most prevalent non-neoplastic causes is portal hypertension mostly due to liver cirrhosis. |
| PubMedID- 24949616 | Partial splenic embolization is an effective interventional procedure performed in liver cirrhosis complicated with portal hypertension to improve the low platelet count. |
| PubMedID- 23787475 | Oct is a somatostatin analogue that has few side effects, and its injection is clinically used for lowering the portal hypertension associated with liver cirrhosis [5]. |
| PubMedID- 25888771 | A 56-year-old chinese man with a history of portal hypertension due to hbv-related liver cirrhosis and known former recurrent esophageal varices bleeding status post sengstaken-blakemore tube tamponade was referred to our hospital for liver transplantation evaluation because of persistent esophagogastric varices bleeding with hypovolemic shock, even after medical and endoscopic therapies in a local hospital. |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22591184 | Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24673975 | Thrombocytopenia: in time, liver cirrhosis leads to portal hypertension. |
| PubMedID- 24914368 | Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21994879 | In our two cases, the patients' risk factors included portal hypertension due to liver cirrhosis, and previous surgery. |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 24331694 | [non-invasive assessment of portal hypertension in patients with liver cirrhosis using fibroscan transient elastography]. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 24812632 | Therefore, intervention of this signaling pathway (particularly inhibition of tgf-β1 levels) may be an important target for the prevention and treatment of portal hypertension due to liver cirrhosis. |
| PubMedID- 23801819 | Subsequent investigations revealed the presence of hepatitis b with secondary liver cirrhosis, complicated by portal hypertension and esophageal varices. |
| PubMedID- 23326153 | We describe a patient with portal hypertension due to liver cirrhosis, who suddenly presented with abdominal hemorrhage and liver laceration 8 d after tips. |
| PubMedID- 24775062 | Pathology such as myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or antithrombin iii as well as hepatocellular carcinoma also could contribute to pvt. |
| PubMedID- 23559324 | Olt was performed at the age of 7 years, due to liver cirrhosis with portal hypertension, in the absence of neurological lesions and an almost-normal brain mri. |
| PubMedID- 24574834 | Variceal bleeding is one of the most fatal complications of portal hypertension in patients with liver cirrhosis [2,17]. |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23964340 | This is because duodenal varices are located deep in the serosal layer, while esophageal varices are located in the submucosal area.3 the most common cause (30%) of duodenal varices is portal hypertension due to liver cirrhosis. |
| PubMedID- 26357501 | The presence of ascites is one of complications of portal hypertension due to advanced liver cirrhosis. |
| PubMedID- 23403613 | The only inclusion criterion was the presence of clinical portal hypertension with intrinsic liver cirrhosis. |
| PubMedID- 26152281 | 3a), which showed that igf-1 was a negative regulating factor in portal hypertension of liver cirrhosis. |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding [16]. |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 23586850 | Reported a 29% in-hospital mortality after colorectal surgery among patients with liver cirrhosis complicated by portal hypertension and 14% in patients with compensated liver cirrhosis [10]. |
| PubMedID- 20534306 | The transjugular intrahepatic portosystemic shunt (tips) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 24963938 | Patients with hcc are predisposed to upper gi haemorrhage as they commonly have portal hypertension either due to underlying liver cirrhosis or due to portal vein involvement by tumour thrombus. |
| PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 21577041 | The main cause of gastroesophageal variceal bleeding (gevb) is portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 22916658 | portal hypertension and varices in patients with liver cirrhosis. |
| PubMedID- 23547461 | [the protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat]. |
| PubMedID- 22878372 | This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
| PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis [1,2]. |
| PubMedID- 25256370 | Background: decreased antithrombin iii (atiii) activity and large splenic vein diameter (svd) are risk factors for portal vein thrombosis (pvt) after splenectomy in liver cirrhosis with portal hypertension. |
Page: 1 2